Viemed Healthcare, Inc., through its subsidiaries, provides in-home health care solutions in the United States. It offers respiratory services and related equipment, including non-invasive ventilators, positive airway pressure machines, and oxygen units, as well as services of respiratory therapists. The company also provides in-home sleep apnea testing to determine the existence of sleep apnea at home. In addition, it leases equipment, including non-invasive ventilators, bi-level devices and CPaP, percussion vests, and various supplies and peripheral equipment, as well as sells medical equipment and patient monitoring services. Further, the company provides therapy, education, and counseling to patients in their homes using technology. Viemed Healthcare, Inc. is headquartered in Lafayette, Louisiana.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CIKN/A
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Viemed Healthcare (CVE:VMD) Frequently Asked Questions
What is Viemed Healthcare's stock symbol?
Viemed Healthcare trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VMD."
What price target have analysts set for VMD?
1 equities research analysts have issued 1-year price objectives for Viemed Healthcare's shares. Their forecasts range from C$12.00 to C$12.00. On average, they expect Viemed Healthcare's stock price to reach C$12.00 in the next year. View Analyst Price Targets for Viemed Healthcare.
What is the consensus analysts' recommendation for Viemed Healthcare?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viemed Healthcare in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Viemed Healthcare.
Has Viemed Healthcare been receiving favorable news coverage?
News stories about VMD stock have trended somewhat positive on Tuesday, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Viemed Healthcare earned a news impact score of 0.9 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Viemed Healthcare.
Who are some of Viemed Healthcare's key competitors?
Some companies that are related to Viemed Healthcare include Cannabix Technologies (BLO), COCHLEAR LTD/ADR (CHEOY), Ellex Medical Lasers (ELXMF), GN Store Nord A/S (GGNDF), Neuroone Medical Technologies (NMTC), Ortho Regenerative Technologies (ORTH), PetVivo (PETV), Quadron Cannatech (QCC), Rafina Innovations (VICA), Sartorius Stedim Biotech (DIM), Sunniva (SNN) and Vycor Medical (VYCO).
What other stocks do shareholders of Viemed Healthcare own?
Who are Viemed Healthcare's key executives?
Viemed Healthcare's management team includes the folowing people:
- Mr. Casey Hoyt, Chief Exec. Officer (Age 41)
- Mr. Michael Moore, Pres
- Mr. Trae Paul Fitzgerald, Chief Financial Officer
- Mr. Todd Zehnder, Chief Operating Officer (Age 43)
- Mr. Kavish Shah, Chief Information Officer
How do I buy shares of Viemed Healthcare?
Shares of VMD and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Viemed Healthcare's official website?
MarketBeat Community Rating for Viemed Healthcare (CVE VMD)
MarketBeat's community ratings are surveys of what our community members think about Viemed Healthcare and other stocks. Vote "Outperform" if you believe VMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
